The service will be available to hospital systems and clinical labs in the state to help increase monkeypox testing efficiency, capacity and turnaround time by using a real-time PCR test, according to a Sept. 6 news release.
Testing will take place at the company’s molecular diagnostics laboratory in Stony Brook, N.Y., which will act as a reference lab to support a high volume of tests from clients in the area.
There are more than 20,000 confirmed cases of monkeypox in the U.S. as of Sept. 6, according to the CDC.
